Aspira Women’s Health Inc. (NYSE: AWH – Get Rating) stock price jumped 8% on Thursday. The company traded as low as $0.98 and last traded at $0.98. 178,530 shares were traded at midday, down 75% from the average session volume of 711,476 shares. The stock had previously closed at $0.90.
A Wall Street analyst gives his opinion
Separately, StockNews.com began covering shares of Aspira Women’s Health in a report on Wednesday, June 1. They issued a “sell” rating for the company.
Aspira Women’s Health Trade Up 8.0%
The company has a fifty-day moving average of $0.73.
Aspira Women’s Health (NYSE: AWH – Get Rating) last released its quarterly results on Wednesday, May 11. The company reported ($0.08) EPS for the quarter, meeting the consensus estimate of ($0.08). The company posted revenue of $1.89 million in the quarter, compared to $2.00 million expected by analysts.
About Aspira Women’s Health
(Get a rating)
Aspira Women’s Health Inc, together with its subsidiaries, engages in the development and commercialization of diagnostic tests for gynecological diseases in the United States. The company provides OVA1, OVERA and OVA1plus to detect the risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecological cancer.
Get news and reviews for Aspira Women’s Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Aspira Women’s Health and related companies with MarketBeat.com’s free daily email newsletter.